Public Reporting

ACO Name & Location

Emergent ACO 24.1, LLC
2323 N. John B Dennis Hwy
Kingsport, TN 37660

ACO Primary Contact

Primary Contact Name: Scott R. Fowler, J.D., M.D.
Primary Contact Phone: 423-857-2091
Primary Contact Email: scott.fowler@myhmg.com

Organizational Information
ACO Participants:
ACO Participants ACO Participant
in Joint Venture
(Enter Y or N)
Galen Medical Group, PC Y
Lagom Health LLC Y
Frontier Health Y
Blue Ridge Radiology, PC Y
Gastroenterology Associates Y
Appalachian Orthopaedic Associates PC Y
Rogersville Vision Center, PLLC Y
East Tennessee Spine and Orthopaedic Specialists, PC Y
Scott O Caudle d/b/a Appalachian Surgery Y
Wesley Primary Care Y
The Reeves Eye Institute Y
FESSS Family Healthcare LLC Y
Family Medicine of Jonesborough, LLC Y
Dr-AL Family and Urgent Care, PLC Y
East Coast Physicians, PC Y
Central Virginia Family Medicine, P.C. Y
Campbell Clinic PC Y
ACO Governing Body:
Name Title Voting Power Membership Type TIN Legal Business Name
Shannon McCallie, MD Director 12.5% ACO Participant Representative Galen Medical Group, PC
Julie Haun, MD Director 12.5% ACO Participant Representative Galen Medical Group, PC
Benjamin Wiley, MD Director 12.5% ACO Participant Representative Galen Medical Group, PC
Charles Famolyin, MD Director 12.5% ACO Participant Representative Wesley Primary Care
Kristie Hammonds Director 12.5% ACO Participant Representative Frontier Health
Jen Stinnet Director 12.5% ACO Participant Representative Lagom Health LLC
Walter Parkhurst, MD Director 12.5% Medicare Beneficiary N/A
Scott R. Fowler, J.D., M.D. Director/President 12.5% Other OnePartner Health Solutions, LLC
Key ACO Clinical & Administrative Leadership:
ACO Executive: Scott R. Fowler, J.D., M.D.
Medical Director: Shelton L. Hager, M.D.
Compliance Officer: Cheryl Stanski, M.D.
Quality Assurance/Improvement Officer: Samantha Sizemore, COO
Associated Committees & Committee Leadership:
Committee Name Committee Leader Name and Position
Clinical Transformation Committee Shelton Hager, MD – Committee Chair
Operations, Quality, Clinical Process, and Population Health Improvement Committee Samantha Sizemore, COO – Committee Chair
Beneficiary Engagement Committee Samantha Sizemore, COO – Committee Chair
Communications & Marketing Committee Samantha Sizemore, COO – Committee Chair
Technology & Data Analytics Committee Byron Salyer – Committee Chair
Contracting & Finance Committee Shawna Armstrong, Treasurer – Committee Co-Chair
Randall Sermons – Co-Chair
Compliance Committee Cheryl Stanski, MD – Committee Chair
Types of ACO Participants, or Combinations of Participants, that Formed the ACO:
  • Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
  • First Agreement Period
    • Performance Year 2024 – $2,963,771.86
Shared Savings Distribution
  • First Agreement Period
    • Performance Year 2025 – TBD
      • Proportion invested in infrastructure: 0%
      • Proportion invested in redesigned care processes/resources: TBD
      • Proportion of distribution to ACO participants: TBD
    • Performance Year 2024
      • Proportion invested in infrastructure: 0%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 80%

2024 Quality Performance Results:

Quality performance results are based on the CMS Web Interface collection type

Measure # Measure Name Collection
Type		 Performance
Rate		 Current Year Mean
Performance Rate
(Shared Savings Program ACOs)
321 CAHPS for MIPS CAHPS for MIPS Survey 5.87 6.67
479* Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups Administrative Claims 0.1324 0.1517
484 * Clinician and Clinician Group Risk standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) Administrative Claims – 37
318 Falls: Screening for Future Fall Risk CMS Web Interface 93.64 88.99
110 Preventative Care and Screening: Influenza Immunization CMS Web Interface 87.21 68.6
226 Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention CMS Web Interface 100 79.98
113 Colorectal Cancer Screening CMS Web Interface 80.65 77.81
112 Breast Cancer Screening CMS Web Interface 87.79 80.93
438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease CMS Web Interface 71.83 86.5
370 Depression Remission at Twelve Months CMS Web Interface 0 17.35
001* Diabetes: Hemoglobin A1c (HbA1c) Poor Control CMS Web Interface 11.25 9.44
134 Preventative Care and Screening: Screening for Depression and Follow-up Plan CMS Web Interface 82.86 81.46
236 Controlling High Blood Pressure CMS Web Interface 84.18 79.49
CAPHS -1 Getting Timely Care, Appointments, and Information CAHPS for MIPS Survey 85.02 83.70
CAPHS -2 How Well Providers Communicate CAHPS for MIPS Survey 92.8 93.96
CAPHS -3 Patient’s Rating of Provider CAHPS for MIPS Survey 91.01 92.43
CAPHS -4 Access to Specialists CAHPS for MIPS Survey 70.82 75.76
CAPHS -5 Health Promotion and Education CAHPS for MIPS Survey 64.45 65.48
CAPHS – 6 Shared Decision Making CAHPS for MIPS Survey 65.66 62.31
CAPHS -7 Health Status and Functional Status CAHPS for MIPS Survey 76.37 74.14
CAPHS -8 Care Coordination CAHPS for MIPS Survey 85.69 85.89
CAPHS – 9 Courteous and Helpful Office Staff CAHPS for MIPS Survey 91.55 92.89
CAPHS -11 Stewardship of Patient Resources CAHPS for MIPS Survey 29.11 26.98

For previous years’ Financial and Quality Performance Results, please visit: Data.cms.gov

*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance.

*For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs’ providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.

Payment Rule Waivers
  • Waiver for Payment for Telehealth Services:
    • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.
  • Fraud and Abuse Waivers
    • ACO Participation Waiver:

      The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.

      • Parties to the arrangement: Emergent ACO 24.1, LLC and Quest Diagnostics, Inc.
      • Date of arrangement: 04/15/2023
      • Items, services, goods, or facility provided: Services
      • No Amendments
      • Summary of Arrangement Conducted Under the ACO Pre-Participation Waiver



Last updated on February 16, 2026